TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 130nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 170nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 500nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 530nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 560nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 600nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 600nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 760nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 780nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 800nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 820nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 830nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 980nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.02E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.12E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.12E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.19E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.20E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.20E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.49E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.51E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.60E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.63E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.63E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.71E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.80E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.85E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.86E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.88E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.90E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.97E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.06E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.11E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.25E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.26E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.28E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.29E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.30E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.33E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.39E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.46E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.48E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.49E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.50E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.52E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.55E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair